Cargando…

Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis

Patient: Male, 39-year-old Final Diagnosis: SARS-CoV-2 Symptoms: Fatigue • dyspnea • fever Medication: Dexamethasone • heparin Clinical Procedure: C-reactive protein apheresis Specialty: Immunology OBJECTIVE: Unusual clinical course BACKGROUND: High C-reactive protein (CRP) plasma levels in severe a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torzewski, Jan, Zimmermann, Oliver, Kayser, Stefan, Heigl, Franz, Wagner, Florian, Sheriff, Ahmed, Schumann, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351245/ https://www.ncbi.nlm.nih.gov/pubmed/34351878 http://dx.doi.org/10.12659/AJCR.932964

Ejemplares similares

First-in-Man: Case Report of Selective C-Reactive Protein Apheresis in a Patient with SARS-CoV-2 Infection
por: Torzewski, Jan, et al.
Publicado: (2020)

Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons
por: Torzewski, Jan, et al.
Publicado: (2022)

A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV) Registry
por: Schumann, Christian, et al.
Publicado: (2022)

“First in Man”: Case Report of Selective C-Reactive Protein Apheresis in a Patient with Acute ST Segment Elevation Myocardial Infarction
por: Ries, Wolfgang, et al.
Publicado: (2018)

Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction—Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study
por: Skarabis, Horst, et al.
Publicado: (2022)

C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study
por: Ries, Wolfgang, et al.
Publicado: (2021)

Selective C‐reactive protein apheresis for Covid‐19 patients suffering from organ damage
por: Kayser, Stefan, et al.
Publicado: (2020)

Selective Apheresis of C-Reactive Protein for Treatment of Indications with Elevated CRP Concentrations
por: Kayser, Stefan, et al.
Publicado: (2020)

Lipoprotein(a)-hyperlipoproteinemia as cause of chronic spinal cord ischemia resulting in progressive myelopathy – successful treatment with lipoprotein apheresis
por: Heigl, Franz, et al.
Publicado: (2017)

Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss
por: Canis, Martin, et al.
Publicado: (2012)

Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels
por: Schettler, Volker J. J., et al.
Publicado: (2015)

The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on
por: Schettler, V. J. J., et al.
Publicado: (2017)

Case Report: C-Reactive Protein Apheresis in a Patient With COVID-19 and Fulminant CRP Increase
por: Ringel, Jens, et al.
Publicado: (2021)

Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease
por: Heigl, Franz, et al.
Publicado: (2015)

Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS)
por: Zaczkiewicz, Myron, et al.
Publicado: (2022)

Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by In Vivo High-Resolution CMR - a comparative analysis
por: Grimm, Jochen M, et al.
Publicado: (2012)

Sweet's Syndrome Successfully Treated with Granulocyte and Monocyte Adsorption Apheresis
por: Fujii, Asami, et al.
Publicado: (2017)

C-Reactive Protein Triggers Cell Death in Ischemic Cells
por: Sheriff, Ahmed, et al.
Publicado: (2021)

LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective
por: Kayikcioglu, Meral
Publicado: (2021)

C-Reactive Protein in Human Atherogenesis: Facts and Fiction
por: Zimmermann, Oliver, et al.
Publicado: (2014)

Apheresis in Neurological Disorders
por: Dorst, Johannes
Publicado: (2020)

Apheresis and Covid-19
por: Griveas, Ioannis
Publicado: (2022)

Seven COVID-19 Patients Treated with C-Reactive Protein (CRP) Apheresis
por: Esposito, Fabrizio, et al.
Publicado: (2022)

Therapeutic apheresis in autoimmune diseases
por: Bambauer, Rolf, et al.
Publicado: (2013)

Therapeutic Apheresis in Metabolic Syndrome
por: Voinov, V.A.
Publicado: (2018)

Familial Hypercholesterolemia and Lipoprotein Apheresis
por: Makino, Hisashi, et al.
Publicado: (2019)

Current Role of Lipoprotein Apheresis
por: Thompson, Gilbert, et al.
Publicado: (2019)

C-Reactive Protein and Arteriosclerosis
por: Torzewski, Jan, et al.
Publicado: (2014)

Infliximab- and Immunosuppressant-Resistant Crohn's Disease Successfully Treated with Adsorptive Granulocyte Apheresis Combined with Prednisolone
por: Itagaki, Munenori, et al.
Publicado: (2012)

LDL-Apheresis: Technical and Clinical Aspects
por: Bambauer, Rolf, et al.
Publicado: (2012)

Role of lipid apheresis in changing times
por: Schuff-Werner, Peter, et al.
Publicado: (2012)

Leukocyte Apheresis in the Management of Ulcerative Colitis
por: Helmy, Ahmed, et al.
Publicado: (2009)

Hyperlipoproteinaemia(a) – apheresis and emerging therapies
por: Vogt, Anja
Publicado: (2017)

Apheresis in Autoimmune Encephalitis and Autoimmune Dementia
por: Rössling, Rosa, et al.
Publicado: (2020)

Safety of Therapeutic Apheresis in Children and Adolescents
por: Taylan, Christina, et al.
Publicado: (2022)

An update on lipid apheresis for familial hypercholesterolemia
por: Taylan, Christina, et al.
Publicado: (2022)

Principles of Therapeutic Apheresis in Neurological Disease
por: Strasser, Erwin
Publicado: (2023)

Two acute psychiatric emergencies and prevalence of mental health disorders at an outpatient apheresis clinic: Implications for apheresis practitioners
por: Williams, Shelly M., et al.
Publicado: (2022)

The effect of DALI lipid apheresis in the prognosis of homozygous familial hypercholesterolemia: Seven patients' experience at a DALI apheresis center
por: Bulut, Muhammet, et al.
Publicado: (2020)

C-reactive protein levels predict systolic heart failure and outcome in patients with first ST-elevation myocardial infarction treated with coronary angioplasty
por: Stumpf, Christian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kms6pbnb46gj3qo8eougocp9eh